tirzepatide for heart failure Effects of on circulatory overload and end-organ damage in with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial SUMMIT: Tirzepatide a 'Huge Win'

These health conditions result from delayed stomach emptying and bile stasis, which are documented side effects of GLP-1 receptor agonists

L.VerinaT.WongD

Haines CJ, Lam PM, Chung TK, Cheng KF, Leung PC

Research consistently shows improved glucose handling and reduced insulin resistance

Despite the widespread use of serotonergic medications, benzodiazepines and cognitive behavioral therapy (CBT), therapeutic outcomes remain limited with less than 50% of patients reaching full remission and nearly one-third do not respond to conventional treatments (De Vries et al., 2016)

These triggers can vary from person to person, and identifying them can play a crucial role in managing IC symptoms effectively